MED17
Basic information
Region (hg38): 11:93784227-93814963
Previous symbols: [ "CRSP6" ]
Links
Phenotypes
GenCC
Source:
- infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly (Strong), mode of inheritance: AR
- infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly (Strong), mode of inheritance: AR
- infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Microcephaly, postnatal progressive, with seizures and brain atrophy | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 20950787 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (40 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MED17 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 213 | 10 | 223 | |||
missense | 75 | 86 | ||||
nonsense | 23 | 28 | ||||
start loss | 0 | |||||
frameshift | 17 | 18 | ||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 15 | 15 | ||||
splice region | 3 | 42 | 1 | 46 | ||
non coding | 93 | 35 | 128 | |||
Total | 40 | 23 | 76 | 313 | 46 |
Highest pathogenic variant AF is 0.0000197
Variants in MED17
This is a list of pathogenic ClinVar variants found in the MED17 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-93784261-C-T | Likely benign (Mar 21, 2019) | |||
11-93784298-A-C | Benign (Jul 26, 2018) | |||
11-93784345-C-T | Likely benign (Aug 30, 2018) | |||
11-93784489-C-T | Likely benign (Jul 07, 2018) | |||
11-93784504-C-T | Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly • MED17-related disorder | Conflicting classifications of pathogenicity (Apr 17, 2020) | ||
11-93784511-A-G | Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly | Uncertain significance (Apr 17, 2020) | ||
11-93784518-C-G | Uncertain significance (Oct 03, 2023) | |||
11-93784519-C-T | Likely benign (Jun 13, 2021) | |||
11-93784521-G-T | Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly • Inborn genetic diseases | Uncertain significance (Nov 23, 2022) | ||
11-93784522-G-C | Likely benign (Oct 06, 2023) | |||
11-93784525-G-A | Likely benign (Nov 23, 2020) | |||
11-93784528-C-G | Likely benign (Jun 30, 2022) | |||
11-93784534-G-T | Likely benign (Oct 14, 2023) | |||
11-93784537-G-A | Likely benign (Dec 16, 2023) | |||
11-93784537-G-C | Likely benign (Oct 03, 2021) | |||
11-93784537-G-T | Likely benign (Sep 05, 2023) | |||
11-93784540-C-T | Likely benign (Feb 04, 2022) | |||
11-93784558-C-T | Likely benign (Dec 26, 2023) | |||
11-93784559-G-T | Pathogenic (Feb 21, 2023) | |||
11-93784567-G-A | Likely benign (Aug 22, 2023) | |||
11-93784570-C-T | Likely benign (Oct 22, 2022) | |||
11-93784573-T-C | Likely benign (Apr 03, 2021) | |||
11-93784582-C-A | Likely benign (Aug 14, 2021) | |||
11-93784583-C-T | Likely benign (Feb 11, 2022) | |||
11-93784600-G-T | Likely benign (Jul 07, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MED17 | protein_coding | protein_coding | ENST00000251871 | 12 | 30469 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.08e-9 | 0.996 | 125700 | 0 | 47 | 125747 | 0.000187 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.878 | 298 | 344 | 0.867 | 0.0000172 | 4263 |
Missense in Polyphen | 71 | 90.435 | 0.7851 | 1127 | ||
Synonymous | 0.598 | 116 | 124 | 0.932 | 0.00000613 | 1218 |
Loss of Function | 2.63 | 20 | 37.3 | 0.536 | 0.00000208 | 395 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000395 | 0.000394 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000285 | 0.000281 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:16595664}.;
- Pathway
- Thyroid hormone signaling pathway - Homo sapiens (human);Developmental Biology;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Transcriptional regulation of white adipocyte differentiation
(Consensus)
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- loftool
- 0.864
- rvis_EVS
- -0.78
- rvis_percentile_EVS
- 12.88
Haploinsufficiency Scores
- pHI
- 0.0872
- hipred
- Y
- hipred_score
- 0.715
- ghis
- 0.619
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.768
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Med17
- Phenotype
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;intracellular steroid hormone receptor signaling pathway;androgen receptor signaling pathway;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;transcription factor complex;membrane;mediator complex;core mediator complex
- Molecular function
- transcription coregulator activity;transcription coactivator activity;protein binding;nuclear receptor transcription coactivator activity;signaling receptor activity;vitamin D receptor binding;thyroid hormone receptor binding